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Abstract For studying the mechanism of cationic
liposome-mediated transmembrane routes for gene
delivery, various inhibitors of endocytosis were used
to treat human throat epidermis cancer cells, Hep-2,
before transfection with Lipofectamine 2000/pGFP-N2
or Lipofectamine 2000/pGL3. To eliminate the effect of
inhibitor toxicity on transfection, the RLU/survival rate
was used to represent the transfection efficiency.
Chlorpromazine and wortmannin, clathrin inhibitors,
decreased transfection efficiency by 44 % (100 lM)
and 31 % (100 nM), respectively. At the same time,
genistein, a caveolin inhibitor, decreased it by 30 %
(200 lM). Thus combined transmembrane routes
through the clathrin and caveolae-mediated pathways
were major mechanisms of cell uptake for the cationic
liposome-mediated gene delivery. After entering the
cells, microtubules played an important role on gene
delivery as vinblastine, a microtubulin inhibitor, could
reduce transfection efficiency by 41 % (200 nM).
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Introduction
Although non-viral vectors are inferior compared to
viral vectors in terms of transfection efficiency, they
have the advantages over viral ones as they are non-
immunogenic, easy to produce and are not oncogenic.
Among non-viral vectors, cationic liposomes are
used extensively as gene carriers for plasmid DNA
(pDNA), antisense oligonucleotides and small inter-
fering RNA (High 2005; Obata et al. 2010). Because
the cell membrane is the first barrier for liposome/
DNA complexes (lipoplexes) to enter into cells, the
mechanism of cationic liposome-mediated transmem-
brane gene delivery is important as a study of it could
contribute to improving transfection efficiency.
Endocytosis is generally considered to be the main
entering pathway for lipoplexes (Chittimalla et al.
2005; Payne et al. 2007). There are however, various
endocytic pathways in eukaryotic cells, such as
clathrin-dependent and clathrin-independent path-
ways. The latter includes phagocytosis, macropinocy-
tosis and caveolae-mediated internalization (Sandvig
et al. 2011). The relative contribution of each pathway
in lipoplexes internalization has been poorly defined to
date (Mayor and Pagano 2007; Howes et al. 2010).
Endocytotic inhibitors, such as chloroquine, chlor-
promazine, NaN3 or filipin, are helpful for studying
drug intracellular release or elucidating a specific
endocytosis route (Blanchard et al. 2006). There are
still many problems that have not been elucidated on
the biological barriers although much effort has been
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expended on them. As non-viral vectors are less
efficient than the viral ones, therefore understanding
the mechanism of transmembrane might contribute to
overcoming the hurdles in gene delivery. This study
was aimed to elucidate the transmembrane pathways
of gene delivery mediated by a cationic liposome,
Lipofectamine 2000, while the inhibitors such as
chlorpromazine (wortmannin), genistein and vinblas-
tine for inhibiting clathrin, caveolin and microtubulin




Human throat epidermis (Hep-2) cancer cell line was
purchased from Cell Bank of Chinese Academy of
Sciences. Lipofectamine 2000 was from Invitrogen. The
pGL3-control (pLuc) vector plasmid (Promega) con-
taining a modified coding region for firefly (Photinus
pyralis) luciferase and the pGFP-N2 vector plasmid
(Clontech) containing a coding region for green fluo-
rescence protein were used for transfection. Bright-Glo
Luciferase Assay System was purchased from Promega.
Cell culture
Hep-2 cells were grown in a 100 ml culture flask in
RPMI-1640 medium supplemented with 10 % (v/v)
FBS and antibiotics (penicillin 100 U/ml and strepto-
mycin 100 U/ml) at 37 C in a humidified atmosphere
containing 5 % (v/v) CO2.
Plasmid preparation
pGL3-control and pGFP-N2 plasmids were amplified
in Escherichia coli (strain JM109 and DH5-a, respec-
tively) and purified using an endotoxin-free kit
(Qiagen) to remove the bacterial endotoxins. The
quantity and quality of purified pDNA were assessed
at 260 and 280 nm by electrophoresis in agarose gels.
Lipoplexes preparation
For the preparation of lipoplexes, 0.3 ll pDNA (pGFP-
N2 or pGL3) (1 mg/ml) and 0.6 ll Lipofectamine 2000
(1 mg/ml), were diluted in Opti-MEM medium 25 ll,
respectively, and then the diluted transfection reagent
was added to pDNA solutions. The mixtures were
vortexed gently and incubated for 20 min at room
temperature for 96 well plate transfection.
Transfection procedure
Hep-2 cells (105 cells/ml) were seeded into 96-well
plates in 100 ll growth medium (RPMI-1640) until
the required cell number was obtained (80 % conflu-
ence) at the time of transfection. Cells were washed
once with PBS, and then 50 ll lipoplexes (prepared as
described above) were added to each well. It was
mixed gently by rocking the plate. The cells were
incubated for 4–6 h, washed by PBS once and the
growth medium was replaced. Cells were further
cultured for 48 h prior to analysis.
Luciferase assay
Relative luciferase activity was assessed using the
Bright-Glo Luciferase Assay System and a microplate
reader. The growth medium was removed from each
well, cells were rinsed once with PBS and luciferase
activity was measured after 100 ll lysis buffer was
added into each well of the 96-well plate with the
incubation of 5 min at room temperature. The protein
concentrations of cell lysates per well were deter-
mined using the BCA protein assay kit, and then the
transfection efficiency was obtained as the relative
luciferase activity. Data were expressed as relative
light units (RLU) per mg protein. Each data point was
averaged over three replicates.
Green fluorescence protein (GFP) assay
The expression of GFP was imaged by inverted
fluorescence microscope and transfection efficiency
was given as relative efficiency. The number of GFP-
expressing cells versus the total cell quantity in the
microscope was defined as the transfection efficiency.
Cell counting was performed randomly in microscopic
observation scope under 10 9 20 magnification with
three repeats.
Cytotoxicity assay
The cytotoxicity was evaluated by MTT assay. Hep-2
cells (105 cells/ml) were seeded into 96-well plates at
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200 ll per well and incubated 24 h before treatment.
Various kinds of inhibitors were added to the cells and
after 1 h, 50 ll MTT (5 mg/ml in PBS) was added and
incubated for an additional 4 h. MTT-containing
medium was removed and 150 ll DMSO was added
to dissolve the formazan and the absorbance was
measured at 570 nm to determine cell survival as
percentage of control. Data were presented as the
mean ± SD.
Results
The effects of clathrin inhibitors on transfection
of lipoplexes
Endocytosis is the main process by which cells take up
macromolecules. However, there are many types of
endocytic pathways, among which the so-called clath-
rin-dependent endocytosis is well characterized. To
determine the influence of clathrin-dependent endocy-
tosis on cationic liposome-mediated transfection,
two inhibitors (chlorpromazine and wortmannin) of
clathrin were used to treat Hep-2 cells before trans-
fection. The transfection efficiency of Lipofectamine
2000/pGFP-N2 complexes was investigated through
the detection of GFP expression (Fig. 1). GFP expres-
sion obviously decreased with increasing inhibitor
concentrations. When chlorpromazine was 100 lM,
GFP expression was very low (Fig. 1a, b). In the same
way, there was significant inhibition when wortmannin
was higher than 60 nM (Fig. 1c, d).
Additionally, luciferase reporter gene was used to
examine the effects of inhibitors on transfection
efficiency. Luciferase activity at 48 h after transfec-
tion was measured (Fig. 2): luciferase gene expres-
sion, as RLU in Hep-2 cells, was reduced by up to
66 % when cells were treated with up to 100 lM
chlorpromazine (Fig. 2a) and by up 72 % when cells
were treated with up to 100 nM wortmannin (Fig. 2c).
The cytotoxicity of chlorpromazine and wortman-
nin was tested by MTT assay, as these inhibitors could
influence cell survival and evaluation of the transfec-
tion efficiency. Cell survival rates were between 87
and 60 % when cells were treated cells chlorproma-
zine (Fig. 2a), and between 79 and 41 % with
wortmannin (Fig. 2c). To minimize the influence of
toxicity of the inhibitors on transfection, the ratios of
RLU to survival rate were used to show the inhibition
of transfection. The RLU/survival rate also decreased
Fig. 1 Effect of concentrations of chlorpromazine
(10–100 lM) and wortmannin (10–100 nM) on GFP expression
mediated by Lipofecamine 2000/pGFP-N2 complexes against
Hep-2 cells. a, c The expression of GFP was imaged by inverted
fluorescence microscope (10 9 20); b, d contrast cells in bright
field. Scale bar = 50 lm
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with an increase of chlorpromazine and wortmannin
concentrations. The expression of protein was reduced
by up to 44 % of the RLU/survival rate with chlor-
promazine up to 100 lM (Fig. 2b). For wortmannin,
expression was reduced by up to 31 % at 100 nM
(Fig. 2d). These results suggested that both chlor-
promazine and wortmannin lower transfection effi-
ciencies by inhibiting clathrin-dependent endocytosis.
The effects of caveolin inhibitor on transfection
of lipoplexes
Besides clathrin-dependent endocytosis, another inter-
nalization pathway is caveolae-dependent. Genistein,
the inhibitor of caveolin, which is essential for the
formation and stability of caveolae, was used to treat
Hep-2 cells 1 h before transfection. Fig. 3 shows
that the transfection efficiency, in terms of GFP
expression, was reduced by up to 80 % with up to
200 lM genistein. Luciferase reporter gene expres-
sion showed that transfection efficiency was reduced
by up to 62 % with genistein up to 200 lM compared
to the control (Fig. 4a). The cytotoxicity of genistein
to cells is shown in Fig. 4a. The ratios of RLU to
survival rate showed the protein expression was
decreased by 30 % with 200 lM genistein (Fig. 4b).
These results demonstrated the route of transmem-
brane transport of lipoplexes by caveolae-dependent
pathway also played an important role.
The effects of microtubule inhibitor
on transfection of lipoplexes
Uptake of materials into cells and subsequent inter-
nalization is usually related to the function of micro-
tubules. Some proteins are trafficked to the nucleus by
Fig. 2 Luciferase reporter gene expression and cell survival
rate. a, c The evaluation of transfection efficiency and cell
survival rate with chlorpromazine (10–100 lM) and wortman-
nin (10–100 nM) treated Hep-2 cells. Lipofectamine 2000 was
used as positive control in transfection. Cell survival rate was
determined with the MTT method with non-treated cells as
control. All results are expressed as mean ± SD (n = 4). b,
d RLU/survival rate with chlorpromazine (10–100 lM) and
wortmannin (10–100 nM) treated Hep-2 cells
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microtubules and are further dismantled in cells.
Vinblastine, which is an inhibitor of microtubule
function, was used to treat cells 1 h before transfec-
tion. Then, in the same way, transfected cells were
detected after the delivery of the reporter genes. The
transfection efficiency of pGFP-N2 was reduced by up
to 98.3 % when cells were treated with up to 200 nM
vinblastine (Fig. 5). The results of luciferase reporter
gene expression showed that transfection efficiency
was reduced by up to 54 % with vinblastine up to 200
nM (Fig. 6a). The cytotoxicity of vinblastine to cells is
shown in Fig. 6a. RLU/survival rate (Fig. 6b) showed
the expression of luciferase gene was reduced by up to
41 % with vinblastine up to 200 nM. These results
indicated that vinblastine could reduce the transfection
efficiency of lipoplexes through inhibiting the func-
tion of microtubulin.
Discussion
Knowledge about the transmembrane uptake mecha-
nism is important for the development of efficient
carriers for gene delivery. So far, some results indicate
that endocytosis is the major mechanism of lipoplexes
entry into cells. There are various endocytic pathways in
eukaryotic cells, among them clathrin-mediated endo-
cytosis functions by means of coated pits and endocytic
internalization. Clathrin-independent endocytic path-
ways include phagocytosis, macropinocytosis and
Fig. 3 Effect of concentrations of genistein (10–200 lM) on GFP expression mediated by Lipofecamine 2000/pGFP-N2 complexes.
a Inverted fluorescent microscope images (10 9 20); b contrast cells in bright field. Scale bar = 50 lm
Fig. 4 Luciferase reporter gene expression and cell survival
rate. a The evaluation of transfection efficiency and cell survival
with genistein (10–200 lM) treated Hep-2 cells. Lipofectamine
2000 was used as positive control. Cell survival rate was
determined with the MTT method with non-treated cells as
control. All results are expressed as mean ± SD (n = 4).
b RLU/survival rate with genistein (10–200 lM) treated Hep-2
cells
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caveolae-mediated endocytosis (Payne et al. 2007;
Ziello et al. 2010). But there are few studies to focus
on the detailed transporting routes of cationic liposome-
mediated gene delivery. This study aimed to elucidate
this problem by using different inhibitors to inhibit the
pathways of cell uptake, hoping to provide reference for
better understanding and overcoming the biological
barriers which exist in the process of gene delivery.
von Gersdorff et al. (2006) showed that chlorprom-
azine inhibition of the clathrin-dependent uptake route
resulted in the loss of transfection with PEI polyplexes
in several cell lines, suggesting that the clathrin-
dependent uptake route is important for successful
transfection. However, combined pathways may func-
tion at the same time. So we used several inhibitors to
study cationic liposome-mediated cell uptake path-
ways. The results showed that chlorpromazine and
wortmannin could reduce transfection efficiency by
30–40 % in terms of RLU/survival rate by inhibiting
clathrin route. Chlorpromazine inhibits uptake path-
way mediated via inhibiting clathrin-coated nest
aggregation in the membrane. Wortmannin inhibits
uptake by affecting the formation of double-shell of
the endosomes to reduce the intracellular endosomal
vesicles (van der Aa et al. 2007). Genistein, as
inhibitor of caveolin, reduced transfection efficiency
by *30 %. Vinblastine could reduce 40 % of trans-
fection efficiency of lipoplexes by inhibiting the
function of microtubulin.
Our results indicated that transfection efficiency
was decreased after incubation with inhibitors, both
through the clathrin- and caveolae-mediated pathways
and also through microtubulin. A correlation between
clathrin-mediated or caveolae-mediated endocytosis
and lipoplexes transfection was supported convinc-
ingly by several lines of evidence, including the use of
Fig. 5 Effect of concentrations of vinblastine (10–200 nM) on GFP expression mediated by Lipofecamine 2000/pGFP-N2 complexes.
a Inverted fluorescent microscope images (10 9 20); b contrast cells in bright field. Scale bar = 50 lm
Fig. 6 Luciferase reporter gene expression and cell survival
rate. a The evaluation of transfection efficiency and cell viability
with vinblastine (10–200 nM) treated Hep-2 cells. Lipofect-
amine 2000 was used as positive control. Cell viability was
determined with the MTT method with non-treated cells as
control. All results are expressed as mean ± SD (n = 4).
b RLU/survival rate with vinblastine (10–200 nM) treated Hep-
2 cells
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inhibitors of endocytosis, co-localization with path-
way-specific markers, and deficiencies in clathrin-
mediated endocytosis. Additionally, the inhibition of
microtubulin probably changed the microtubule func-
tion for lipoplexes transport through microtubule
polymerization by the addition of vinblastine. Cell
uptake and subsequent internalization is usually
related to the function of microtubule. The cytoskel-
eton is required for the formation and internalization
of clathrin-coated pits (Yarar et al. 2005). Vinblastine
can affect the actin cytoskeleton grouping into actin
filament polymerization orderly and promote its
dissociation. Therefore, it can inhibit the uptake
pathway mediated by microtubule and microfilament.
The use of inhibitors might give rise to an
unambiguous outcome because of toxic side-effects
(Chittimalla et al. 2005). So we took the cell survival
rate into account during the uptake study of lipoplexes
into cells. The ratios of RLU to survival used in this
paper, could better address the problem caused by the
toxicity of inhibitors.
Taken together, these results demonstrated that the
uptake of lipoplexes to Hep-2 cells was mediated via
both the clathrin-mediated and caveolae-mediated
endocytic pathways. Otherwise, phagocytosis medi-
ated by microtubule-microfilament also played a role
in the regulation. There is no doubt that the combined
action of these endocytic pathways is essential for
gene delivery, and their roles will be clarified further
as the studies continue. Though we need to further
elucidate the functions of inhibitors and more detailed
mechanism of liposomes mediated transfection, the
results of this article could provide reference for the
acquisition of novel gene delivery systems.
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